BTRX-246040

DB16048InvestigationalSmall molecule

BTRX-246040 is under investigation in clinical trial NCT03193398 (BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder).

Chemical structure of BTRX-246040
Mechanism
Curator reviewed
Formula / weight
C22H23ClF2N4O2S · 480.96 g/mol (avg)
Code names
BTRX-246040 · J3.309.394B · LY-2940094

Resolves to

Compound
UNII4I67US2V8QCAS1307245-86-8ChEMBLCHEMBL3304244
Structure
InChIKeyNKQHBJNRBKHUQR-UHFFFAOYSA-NSMILESCC1=NN(C=C1CN1CCC2(CC1)OCC(F)(F)C1=C2SC(Cl)=C1)C1=NC=CC=C1CO
Targets
P41146OPRL1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with BTRX-246040, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In